Long thought of as a bystander in pathophysiological processes, lipid molecules have
emerged as bioactive mediators of cardiovascular pathology. There has been accumulating …

There is increasing clinical evidence that phospholipid oxidation products (Ox-PL) play a
role in atherosclerosis. This review focuses on the mechanisms by which Ox-PL interact with …

Lipid oxidation products and in particular oxidized phospholipids (OxPL) are increasingly
recognized as inducers of chronic inflammation characteristic of atherosclerosis. OxPL …

Prolonged or excessive exposure to oxidized phospholipids (OxPLs) generates chronic
inflammation. OxPLs are present in atherosclerotic lesions and can be detected in plasma …

Since the discovery of oxidized phospholipids (OxPL) and their implication as modulators of
inflammation in cardiovascular disease, roles for these lipid oxidation products have been …

Phospholipids containing polyunsaturated fatty acids are highly prone to modification by
reactive oxygen species. They tend to undergo lipid peroxidation to form OxPLs which …

Oxidised phospholipids (OxPLs) are generated from (poly) unsaturated diacyl-and alk (en)
ylacyl glycerophospholipids under conditions of oxidative stress. OxPLs exert a wide variety …

There is increasing evidence that oxidized phospholipids (OxPLs) play an important role in
atherosclerosis. These phospholipids accumulate in human and mouse lesions. Specific …

Oxidized phospholipids (OxPLs) are increasingly recognized to play a role in a variety of
normal and pathological states. OxPLs were implicated in regulation of inflammation …

Oxidized phospholipids (OxPLs), complex mixtures of phospholipid oxidation products
generated during normal or pathological processes, are increasingly recognized to show …